Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02455297
Title Phase IIa Study of Copanlisib in Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications

mantle cell lymphoma

Therapies

Copanlisib

Age Groups: adult
Covered Countries USA


No variant requirements are available.